MedPath

Effect of ciprofloxacin on advanced chronic periodontitis

Phase 2
Conditions
sever chronic periodontitis.
Chronic periodontitis Chronic pericoronitis
Registration Number
IRCT2017061734582N1
Lead Sponsor
zahdan university of medical siences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Inclusion Criteria :Age upper 18 years old? Presence of twenty teeth of least?Affection with spread mean to severe chronic periodontitisAt least (3-5 min clinical attachment loss in more thou 30 percent of the mouth areas .

Exclusion criteria: Lack of patient’s coloration? Antibiotic therapy doing the third past months?Allergy background for ciprofloxacin? Smoking people or addicted to tobacco? Affection with systemic diseases , which are effective on the periodontal conditions such as diabetes , blood disorders and immune system?
Pregnant women? Periodical Intervention Performance during the third past months?People who are under treatment with warfarin , antacid T and Cyclosporine.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gingival bleeding index(GBI). Timepoint: the first, scond and fourth months. Method of measurement: bleeding-non bleeding.;Probing depth(PD). Timepoint: the first, scond and fourth months. Method of measurement: Based on Periodontal Probe williams.;Clinical attachment level(CAL). Timepoint: the first, scond and fourth months. Method of measurement: Based on Periodontal Probe williams.;Drug. Timepoint: First month for 7 days, two capsules a day. Method of measurement: Based on the presence or absence of consumption.;Time. Timepoint: the first, scond and fourth months. Method of measurement: Based on the onset of a therapeutic intervention.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath